Angel Oak Financial Strategies Income Term Trust Declares July 2025 Distribution
The Fund seeks to pay a distribution at a rate that reflects net investment income actually earned. A portion of each distribution may be treated as paid from sources other than net investment income, including but not limited to short-term capital gain, long-term capital gain, or return of capital. As required by Section 19(a) of the Investment Company Act of 1940, a notice will be distributed to shareholders in the event that a portion of a monthly distribution is derived from sources other than undistributed net investment income. The final determination of the source and tax characteristics of these distributions will depend upon the Fund's investment experience during its fiscal year and will be made after the Fund's year end. The Fund will send to investors a Form 1099-DIV for the calendar year that will define how to report these distributions for federal income tax purposes. Angel Oak does not provide tax advice; shareholders should consult their tax advisor. A return of capital distribution does not necessarily reflect a fund's investment performance and should not be confused with 'yield' or 'income.'
ABOUT FINS
Led by Angel Oak's experienced financial services team, FINS invests predominantly in U.S. financial sector debt as well as selective opportunities across financial sector preferred and common equity. Under normal circumstances, at least 50% of FINS' portfolio is publicly rated investment grade or, if unrated, judged to be of investment grade quality by Angel Oak.
ABOUT ANGEL OAK CAPITAL ADVISORS, LLC
Angel Oak Capital Advisors is an investment management firm focused on providing compelling fixed-income investment solutions to its clients. Backed by a value-driven approach, Angel Oak Capital Advisors seeks to deliver attractive, risk-adjusted returns through a combination of stable current income and price appreciation. Its experienced investment team seeks the best opportunities in fixed income, with a specialization in mortgage-backed securities and other areas of structured credit.
Information regarding the Fund and Angel Oak Capital Advisors can be found at www.angeloakcapital.com.
Past performance is neither indicative nor a guarantee of future results. Investors should consider the investment objective and policies, risk considerations, charges and ongoing expenses of an investment carefully before investing. For more information please contact your investment representative or Destra Capital Advisors LLC at 877.855.3434.
© 2025 Angel Oak Capital Advisors, which is the investment adviser to the Angel Oak Financial Strategies Income Term Trust.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Akre Capital's Akre Focus Fund 2nd-Quarter 2025 Letter: A Review
Greetings from Middleburg. We hope your summer is off to a good start. The Akre Focus Fund's (the Fund) second quarter 2025 performance for the Institutional share class was 6.46% compared with S&P 500 Total Return of 10.94%. Performance for the trailing 12-month period ending June 30, 2025, for the Institutional share class was 20.43% compared with 15.16% for the S&P 500 Total Return. Warning! GuruFocus has detected 7 Warning Signs with TSX:CSU. We recently read a very interesting report by Morgan Stanley's Michael Mauboussin and Dan Callahan entitled Drawdowns and Recoveries: Base Rates for Bottoms and Bounces (1). We were hooked from the opening sentence: One of the hardest aspects of being a long-term investor is that even the best investments, or investment portfolios, suffer large drawdowns. A drawdown is the price decline from peak to trough. For us, the report's key findings were as follows: Large drawdowns indeed! The report cites a study of roughly 28,600 public companies from 1926 through 2024. The top six of these in terms of wealth creation (Apple, Microsoft, NVIDIA, Alphabet, Amazon, ExxonMobil) suffered an average maximum drawdown of 80.3%! Amazon's share price dropped 95% from December 1999 to October 2001, for example. Nvidia's dropped 90% from January 2002 to October 2002. The study by Messrs. Mauboussin and Callahan involved 6,500 US stocks from 19852024. The median stock price recovery from the drawdown bottom was 89.6% of the pre-drawdown peak (a.k.a. par). In other words, the median stock failed to return to its prior peak after max drawdowns: a permanent loss of capital for those who bought high. Returns from the bottom of these drawdowns were spectacular even if the stock failed to return to par. Intuitively, the bigger the drawdown, the bigger the subsequent return from the bottom. As the report points out, buying at the very bottom of a drawdown is highly unlikely. But it holds that the lower one buys during a drawdown, the higher the subsequent return. The role business quality played in terms of long-term compounding was of particular interest to us. In this report, the proxy for business quality was the extent of the drawdown: the smaller the drawdown, the higher the business quality, and vice versa. Critically, the study shows that while the largest drawdown (lowest quality) businesses produced the highest returns from the bottom, they generally did not compound from their pre-drawdown peak. Specifically, the quintile of stocks with the largest drawdowns recovered just 80% of prior peak value five years after the drawdown bottom. On the other hand, the quintile of stocks with the smallest drawdowns (a.k.a. the highest quality stocks) nearly doubled in value from their prior peak value five years after bottoming. In rough math, given the seven-year time frame of the study (two-year drawdown followed by five years of recovery), the lowest quality businesses compounded at negative 3.1% annually from peak to recovery, declining from an indexed peak of $100 to $80 seven years later. The highest quality businesses compounded at positive 9.6% annually over those seven years, increasing from an indexed peak of $100 to approximately $190 seven years later. We cannot directly map these research findings to our portfolio or investment approach, particularly the correlation of drawdown depth to business quality. However, we believe the findings corroborate our long-held notion that a compounding investment approach has subtle but important distinctions from value investing. Those distinctions center on the primacy of business quality. Per the Morgan Stanley study (2), high quality businesses generally compounded positively over time, even from their pre-drawdown peak. Low quality businesses, which declined more and bounced higher off the bottom, generally did not. These findings reminded us of what we did, and did not do, during the sharp but short-lived COVID bear market of March 2020, a month during which we bought over $1.1 billion in equities. We did not buy the COVID ground zero names such as airlines and cruise lines, both among the hardest hit, deepest value sectors at the time. Value investors might reasonably look to play the bounce in such sectors. If you bought the all-airline US Global Jets ETF (JETS) on March 30, 2020, you made an 85.62% return after just one year! The harder the fall, the higher the bounce. To our way of thinking, however, airlines are not high-quality businesses. And indeed, that lack of quality weighed on their longer-term rate of compounding. By the second anniversary of that well-timed JETS purchase, the annual rate of return dropped to 22.31%. By June 30, 2025, the annualized return off the bottom stood at 9.15% [per Bloomberg]. The equity investments we made in March 2020 bounced less but have compounded more. A year later, as of March 30, 2021, our March 2020 investments in aggregate had appreciated 74.85%, excluding dividends. A nice rebound, to be sure, but less than that achieved by the harder hit, lower quality airline stocks. However, quality and compounding show over time. Our March 2020 equity investments in total would have compounded at approximately 19.07% annualized if all were held through June 30, 2025, excluding dividends. The investments we made in March 2020 and have held through June 30, 2025, have compounded at approximately 21.67% excluding dividends. We believe compounding-driven investors are distinguished by an emphasis on quality and quality's tendency to reward longer holding periods. Warren Buffett (Trades, Portfolio)'s adage, If you aren't thinking about owning a stock for ten years, don't even think about owning it for ten minutes, captures this distinction between compounding and bounce-seeking value investing. Furthermore, we think of traditional value investing as seeking to buy the proverbial $1 of intrinsic value for ~$0.60, sell at $0.85 or $0.90, rinse and repeat. For value investors, valuation is the primary investment (buy and sell) consideration. And there's nothing wrong with this whatsoever. However, in our view, such an approach implies a somewhat commoditized view of businesses as easily exchangeable like-for-like. We believe business quality is just as important as starting valuations if the goal is to compound capital at an attractive rate over the longest time. We endeavor to own the highest quality businesses we can understand and buy them only at attractive valuations. The Morgan Stanley study supports this notion that high business quality is key to long-term compounding, even from pre-drawdown peaks. Obviously, compounding is easier said than done. Even when done exceptionally well, an active manager is prone to getting fired during the inevitable sharp drawdown or its aftermath. Indeed, the Morgan Stanley piece cites another of our favorite reads of recent years, Wes Gray's Even God Would Get Fired as an Active Investor. Dr. Gray constructs portfolios consisting only of the 50 best performing stocks over five-year periods starting January 1, 1927. Every five years, these portfolios are reset to include only the 50 best performers over the next five years. Calling these God Portfoliosbuilt with perfect foresight to contain only the best performing stocks over each five-year periodthese portfolios performed brilliantly, with annualized returns over the study period (1927 through 2016) three times that of the S&P 500. However, even these perfect portfolios were subject to significant drawdowns, the worst being 76% (August 1929 to May 1932) along with five drawdowns of 30% and higher. As Messrs. Mauboussin and Callahan say, Even the perfect portfolio tests the resolve of those who own it. Even for the best performing stocks and the best performing portfolios, faith-testing drawdowns are inevitable. The Morgan Stanley study supports our long-held view that a dual focus on business quality and starting valuation are the keys to long-term compounding. The top five contributors to performance during the quarter were Constellation Software (TSX:CSU), Brookfield Corporation (NYSE:BN), (TOITF), KKR (NYSE:KKR), and Moody's (NYSE:MCO). No callouts worth mentioning. The top four detractors from performance this quarter were O'Reilly Automotive (NASDAQ:ORLY), Roper Technologies (NASDAQ:ROP), LVMH (LVMUY), and Danaher (NYSE:DHR). As of June 30, cash and equivalents stood at 8.1% of the Fund, up from 6.3% on March 31 and 1.4% on December 31st. We have made a point of raising our cash position in case our valuation discipline and patience gets rewarded in the weeks and months ahead. Over the life of the Fund, we have routinely held cash in the 5-10% range. Finally, as announced in the supplement to the Akre Focus Fund's Prospectus dated June 4, 2025, we received approval from the Board of Trustees to convert the Fund from a mutual fund to an exchange traded fund. The ETF structure is expected to offer enhanced tax efficiency, greater trading flexibility, and increased transparency of portfolio holdings. The investment process and investment team will remain the same. We thank you for your exceptional support. John The Fund's investment objectives, risks, charges, and expenses must be considered carefully before investing. The summary and statutory prospectus contains this and other important information about the investment company and it may be obtained by calling (877) 862-9556 or visiting Read it carefully before investing. Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Fund performance current to the most recent month-end may be lower or higher than the performance quoted and can be obtained by calling 1-877-862-9556. The Fund's annual operating expense (gross) for the Retail Class shares is 1.31% and 1.04% for the Institutional Class shares. The Fund imposes a 1.00% redemption fee on shares held less than 30 days. Performance data does not reflect the redemption fee, and if reflected, total returns would be reduced. Mutual fund investing involves risk. Principal loss is possible. The Fund is non-diversified, meaning it may concentrate its assets in fewer individual holdings than a diversified fund. Therefore, the Fund is more exposed to individual stock volatility than a diversified fund. In addition to large- capitalization companies, the Fund invests in small- and medium- capitalization companies, which involve additional risks such as limited liquidity and greater volatility than larger capitalization companies. (1) Drawdowns and Recoveries: Base Rates for Bottoms and Bounces (2) Drawdowns and Recoveries: Base Rates for Bottoms and Bounces This article first appeared on GuruFocus.
Business Wire
5 hours ago
- Business Wire
Heritage Group Closes on $370 Million Fourth Fund
NASHVILLE, Tenn.--(BUSINESS WIRE)--Heritage Group, a healthcare-focused private equity firm, today announced the final closing of Heritage Healthcare Innovation Fund IV ('Fund IV' or the 'Fund') at over $370 million, marking another significant milestone in the firm's continued growth. Fund IV builds on Heritage Group's successful strategy of making minority and majority investments in solution-oriented, high-growth healthcare services and technology businesses that address the industry's most pressing challenges. Heritage Group's deep strategic engagement model ensures that their health system and payer limited partners add value throughout the investment lifecycle—from sourcing and diligence to portfolio company growth and commercialization. Share 'We are grateful for the continued support from our longtime investors and excited to welcome several new limited partners to Fund IV,' said Jesse Bland, Partner at Heritage Group. 'Their confidence reflects the strength of our strategic model and our ability to identify and scale businesses across some of the highest growth subsectors of the healthcare ecosystem.' Heritage is backed by leading healthcare organizations, including major health systems operating more than 800 hospitals, payers insuring over 75 million lives, and other key healthcare service providers. 'Our strategic investors aren't just capital providers—they're true partners in how we source, evaluate, and grow businesses,' said Bryan Bui, Partner at Heritage Group. 'We work hard to maintain a two-way dialogue with our limited partners, ensuring they have early and direct access to emerging innovation while also bringing their insights into every stage of our investment process.' Heritage Group's deep strategic engagement model ensures that their health system and payer limited partners add value throughout the investment lifecycle—from sourcing and diligence to portfolio company growth and commercialization. This strategic investment approach provides proprietary insights and real-time market intelligence, enabling Heritage to take a thematic approach to investing by targeting segments of the healthcare industry positioned for meaningful and sustained growth. 'Heritage enables us to engage directly with some of the most forward-thinking healthcare companies in the market,' said Tim Hingtgen, CEO of Community Health Systems. 'Their ability to surface emerging trends early, connect us with innovative solutions, and create meaningful opportunities for strategic collaboration across the ecosystem makes them a uniquely valuable partner.' Heritage Group's portfolio spans several high-impact themes including the shift to lower-cost sites of care, such as ambulatory infusion (TwelveStone) and home-based care (Upward Health); enabling value-based care through companies like Curana Health and Wellvana; supporting health systems through outsourced clinical services (Equum, a leader in teleICU and telenursing, and Shearwater Health, a clinical process outsourcer); and expanding access to care via platforms such as MDLIVE and Connections Health Solutions. 'Heritage has been an invaluable partner to our team—delivering strategic value well beyond capital,' said David Siegel, CEO of Nationwide Medical, a Heritage Group portfolio company. 'Their deep understanding of the healthcare landscape, collaborative approach, and strategic connectivity have helped us accelerate growth and expand our impact in meaningful ways.' About Heritage Group Heritage Group is a Nashville, Tennessee-based, healthcare-focused private equity firm with more than 40 years of experience financing and operating healthcare companies. Heritage has over $1 billion of assets under management and seeks to make majority and minority investments in high-growth healthcare services and healthcare technology businesses that address the challenges of the U.S. healthcare system. The firm's limited partners include some of the leading healthcare organizations in the nation, including large provider systems, payers, and healthcare service providers, which collectively operate over 800 hospitals and insure more than 75 million lives. For more information, visit
Hamilton Spectator
6 hours ago
- Hamilton Spectator
Middlefield Global Infrastructure Dividend ETF Distributions
TORONTO, July 24, 2025 (GLOBE NEWSWIRE) — Middlefield Global Infrastructure Dividend ETF (TSX: MINF) (the 'Fund') is pleased to announce that distributions for the third quarter of 2025 will be payable to unitholders of Middlefield Global Infrastructure Dividend ETF as follows: The trust units trade on the Toronto Stock Exchange under the symbol MINF. The Fund offers a distribution reinvestment plan ('DRIP') for unitholders which provides unitholders with the ability to automatically reinvest distributions, commission free, and realize the benefits of compound growth. Unitholders can enroll in the DRIP program by contacting their investment advisor. Middlefield Founded in 1979, Middlefield is a specialist equity income asset manager with offices in Toronto, Canada and London, England. Our investment team utilizes active management to select high-quality, global companies across a variety of sectors and themes. Our product offerings include proven dividend-focused strategies that span real estate, healthcare, innovation, infrastructure, energy, diversified income and more. We offer these solutions in a variety of product types including ETFs, Mutual Funds, Closed-End Funds, Split-Share Funds and Flow-through LPs. For further information, please visit our website at or contact Nancy Tham in our Sales and Marketing Department at 1.888.890.1868. This press release contains forward-looking information. The forward-looking information contained in this press release is based on historical information concerning distributions and dividends paid on the securities of issuers historically included in the portfolio of the Fund. Actual future results, including the amount of distributions paid by the Fund, may differ from the monthly distribution amount. Specifically, the income from which distributions are paid may vary significantly due to: changes in portfolio composition; changes in distributions and dividends paid by issuers of securities included in the Fund's portfolio from time to time; there being no assurance that those issuers will pay distributions or dividends on their securities; t he declaration of distributions and dividends by issuers of securities included in the portfolio will generally depend upon various factors, including the financial condition of each issuer and general economic and stock market conditions; the level of borrowing by the Fund; and the uncertainty of realizing capital gains. The risks, uncertainties and other factors that could influence actual results are described under 'Risk Factors' in the Fund's prospectus and other documents filed by the Fund with the Canadian securities regulatory authorities. The forward-looking information contained in this press release constitutes the Fund's current estimate, as of the date of this press release, with respect to the matters covered hereby. Investors and others should not assume that any forward-looking statement contained in this press release represents the Fund's estimate as of any date other than the date of this press release.
